CIK 0001266806
- Non-accelerated filer
- Smaller reporting company
Vivani Medical, Inc.
Sign in to watch- Ticker
- VANI
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 020692322
- Phone
- +1 415-506-8462
- Business address
- 1350 S. LOOP ROAD, ALAMEDA, CA, 94502
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC, SECOUND SIGHT MEDICAL PRODUCTS INC
- Open-market buys, last 90 days
- $67,408
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$67,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-31 | OKLAND STEPHEN D Chief Commercial Officer | Grant or award | +7,435 | $1.16 | $9K | 31,076 |
| 2018-05-31 | McGuire Jonathan Will Chief Executive Officer | Grant or award | +10,582 | $1.16 | $12K | 107,700 |
| 2018-05-31 | Randolph Edward David Vice President - Manufacturing | Grant or award | +16,023 | $1.16 | $19K | 16,045 |
| 2018-05-31 | Williams Gregg Director | Purchase | +15,602 | $1.98 | $31K | 26,267,281 |
| 2018-05-30 | Williams Gregg Director | Purchase | +12,350 | $1.98 | $24K | 26,251,679 |
| 2018-05-21 | McGuire Jonathan Will Chief Executive Officer | Sale | −3,755 | $2.18 | $8K | 97,118 |
| 2018-05-18 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | 100,873 | ||
| 2018-05-18 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Unit (RSU) | −11,875 | 59,375 | ||
| 2018-05-16 | OKLAND STEPHEN D Commercial V.P, North America | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-05-03 | Williams Gregg Director | Purchase | +4,729,730 | $1.48 | $7.0M | 24,212,302 |
| 2018-05-03 | Williams Gregg Director | Purchase | +2,027,027 | $1.48 | $3.0M | 26,239,329 |
| 2018-03-09 | McGuire Jonathan Will Chief Executive Officer | Returned to the company | −4,216 | $1.69 | $7K | 88,998 |
| 2018-03-08 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | $1.73 | $21K | 93,214 |
| 2018-03-08 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Unit (RSU) | −11,875 | 71,250 | ||
| 2018-02-19 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Units(RSUs) | −11,875 | 23,750 | ||
| 2018-01-19 | MILLER THOMAS B Chief Financial Officer | Grant or award · Non-qualified Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-01-04 | Jacques David Murray VP-Research Development | Grant or award · Non-Qualified Option (right to buy) | +125,000 | 125,000 | ||
| 2018-01-04 | Randolph Edward David Vice President of Manufacturin | Grant or award · Non-Qualified Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2018-01-04 | Greenberg Robert J. Chairman of Board | Grant or award · Non-Qualified Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2018-01-04 | McGuire Jonathan Will Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | −450,000 | 450,000 |
Page 27 of 31 · 601 trades